Phase II trial of ATx08-001 in patients with postherpetic neuralgia.

Trial Profile

Phase II trial of ATx08-001 in patients with postherpetic neuralgia.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2011

At a glance

  • Drugs ATx08 001 (Primary)
  • Indications Postherpetic neuralgia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Dec 2011 Primary endpoint 'Pain-intensity' has been met.
    • 19 Aug 2011 Actual end date (1 Jul 2011) added as reported by ClinicalTrials.gov.
    • 19 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top